Tuberculosis Diagnostic Delays and Treatment Outcomes among Patients with COVID-19, California, USA, 2020
- PMID: 38147063
- PMCID: PMC10756354
- DOI: 10.3201/eid3001.230924
Tuberculosis Diagnostic Delays and Treatment Outcomes among Patients with COVID-19, California, USA, 2020
Abstract
We assessed tuberculosis (TB) diagnostic delays among patients with TB and COVID-19 in California, USA. Among 58 persons, 43% experienced TB diagnostic delays, and a high proportion (83%) required hospitalization for TB. Even when viral respiratory pathogens circulate widely, timely TB diagnostic workup for at-risk persons remains critical for reducing TB-related illness.
Keywords: COVID-19; California; SARS-CoV-2; TB; United States; bacteria; coronavirus disease; coronaviruses; deaths; diagnostic delay; hospitalization; respiratory infections; severe acute respiratory syndrome coronavirus 2; treatment outcomes; tuberculosis; viruses.
Figures


References
-
- World Health Organization. Global tuberculosis report 2021. [cited 2022 Apr 27]. https://www.who.int/publications/i/item/9789240037021
-
- Nabity SA, Fong V, Keh C, Flood J. Disruptions to TB program services and capacity during the COVID-19 response in California, January 2020–August 2021. In: Abstracts of the National TB Controllers Association/California TB Controllers Association Conference, 2022. Palm Springs, CA, USA; 2022 May 23–26. Smyrna (GA): National TB Controllers Association; 2022.
-
- Nabity SA, Han E, Lowenthal P, Henry H, Okoye N, Chakrabarty M, et al. Sociodemographic characteristics, comorbidities, and mortality among persons diagnosed with tuberculosis and COVID-19 in close succession in California, 2020. JAMA Netw Open. 2021;4:e2136853. 10.1001/jamanetworkopen.2021.36853 - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous